Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Patricia Morgan

Product Marketing Manager

Connect with Patricia Morgan on LinkedIn

About the author: Patricia has extensive experience in the life sciences industry, with broad experience in products and services in the Molecular Diagnostic, Life Sciences and Pharmaceutical segments. Her roles have involved defining product specifications and marketing programs for emerging technologies such as toxicogenomics and pathway analysis tools that enable researchers to gain molecular insights into diseases and protein interactions. She holds an MBA from Loyola College in Maryland and a BA in Microbiology from University of Maryland College Park.

Posts by Patricia Morgan

The Importance of Selecting The Most Promising Drug Target

Posted on September 27th, 2017 in Pharma R&D

The growing economic pressure due to late-stage drug approval failures has been forcing drug discovery and development scientists to adapt their strategies in order to increase their chances of success. (more…)

Harnessing the Power of Content in Scientific Research

Posted on September 11th, 2017 in Pharma R&D

Biological research today can be summarized in one word — data.

Massive quantities of information are generated daily from large and small laboratories, individuals, universities, and commercial organizations. (more…)

Selecting Anti-Melanoma Drug Targets

Posted on August 28th, 2017 in Pharma R&D

Every year, hundreds of thousands of people are diagnosed with melanoma, the most deadly form of skin cancer. Although rates of melanoma have continued to rise over the last three decades (more…)

Cancer Immunotherapy Webinar on September 12: Register Now

Posted on August 25th, 2017 in Pharma R&D

After decades of being treated with a fairly typical combination of surgery and therapies, cancer is now being met with exciting new treatments that are more targeted and often less hard on the patient. (more…)

  1. 1
  2. 2
  3. 3